Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring Solution: Prospective, Randomized, Multicenter Trial FEGALA

NCT06379880 is registered in ClinicalTrials.gov with Centre Paul Strauss as lead sponsor.

NCT NCT06379880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06379880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring Solution: Prospective, Randomized, Multicenter Trial FEGALA
Lead sponsor
Centre Paul Strauss
Phase
Not applicable
Overall status
Completed
Start date
April 25, 2024
Completion date
January 26, 2026
Enrollment
411 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms, colorectal neoplasms, lung neoplasms, prostatic neoplasms